BIOTHERAPEUTICS DEVELOPABILITY
AND RISK MITIGATION

SCIENTIFIC ADVISORY BOARD

Alain Beck

Senior Director, Biologics CMC & developability

Centre d'Immunologie Pierre Fabre

Roland Beliard

Business Development Director

LFB Biomanufacturing

Nicola Beltraminelli

Chief Development Officer

Innate Pharma

Hervé Broly

Executive CMC Consultant for Biologics

Merck

Cédric Charretier

Global Head Vaccine Drug Substance Development, Vaccine CMC Development Supply

Sanofi

Olivier Cochet

Head of Biotech Developpment and Supply

Debiopharm

Arnaud Delobel

R&D Director Strategy & Innovation

Quality Assistance

Sophie Derenne

Head of the Department Analysis and Market Development

Etablissement Français du Sang (EFS)

Annick Gervais

Head of Analytical Development Sciences

UCB Pharma

Michaël Lanero Fidalgo

Chief Operating Officer

TreeFrog Therapeutics

Oumeya (Mia) Adjali

Senior Scientist in Gene Therapy, Head of TaRGeT laboratory

INSERM

Nathalie Heuzé-Vourc'h

Research Professor Inserm, Deputy director "Health Technologies" Institute

INSERM

Miliza Diab

Upstream lab lead - MSAT

Novartis

John Churchwell

Associate Lead Scientist

Catapult

Guillaume Rousseau

MSAT Site lead

Sanofi Vitry